Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE; SCOT Study Investigators. Sullivan KM, et al. N Engl J Med. 2018 Jan 4;378(1):35-47. doi: 10.1056/nejmoa1703327. N Engl J Med. 2018. PMID: 29298160 Free PMC article. Clinical Trial.
Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA Jr, Seibold JR; Relaxin Study Group; Scleroderma Clinical Trials Consortium. Khanna D, et al. Among authors: korn jh. J Rheumatol. 2005 May;32(5):832-40. J Rheumatol. 2005. PMID: 15868618 Clinical Trial.
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.
White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, Lachenbruch PA, LeRoy EC, Mitrane MP, Paulus HE, et al. White B, et al. Among authors: korn jh. Arthritis Rheum. 1995 Mar;38(3):351-60. doi: 10.1002/art.1780380309. Arthritis Rheum. 1995. PMID: 7880189
Immunologic aspects of scleroderma.
Korn JH. Korn JH. Curr Opin Rheumatol. 1991 Dec;3(6):947-52. doi: 10.1097/00002281-199112000-00009. Curr Opin Rheumatol. 1991. PMID: 1772749 Review.
Immunologic aspects of scleroderma.
Korn JH. Korn JH. Curr Opin Rheumatol. 1990 Dec;2(6):922-8. doi: 10.1097/00002281-199002060-00009. Curr Opin Rheumatol. 1990. PMID: 2083158 Review. No abstract available.
Biology of the scleroderma fibroblast.
Strehlow D, Korn JH. Strehlow D, et al. Among authors: korn jh. Curr Opin Rheumatol. 1998 Nov;10(6):572-8. doi: 10.1097/00002281-199811000-00011. Curr Opin Rheumatol. 1998. PMID: 9812218 Review.
Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma).
Atamas SP, Luzina IG, Ingels J, Choi J, Wong WK, Furst DE, Clements PJ; Investigators of the Oral Collagen Trial in Scleroderma; Postlethwaite AE. Atamas SP, et al. Clin Exp Immunol. 2010 Sep;161(3):426-35. doi: 10.1111/j.1365-2249.2010.04189.x. Clin Exp Immunol. 2010. PMID: 20529088 Free PMC article.
133 results